Skip to content

A study to compare the effect of Morphine (an opioid) versus Butorphanol ( an opioid) in surgeries below umbilicus performed under anesthesia

A PROSPECTIVE RANDOMIZED DOUBLE BLINDED STUDY TO COMPARE THE EFFECT OF INTRATHECAL MORPHINE VERSUS INTRATHECAL BUTORPHANOL IN INFRAUMBILICAL SURGERIES PERFORMED UNDER SUBARACHNOID BLOCK

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/05/033800
Enrollment
160
Registered
2021-05-25
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: TO COMPARE THE EFFECT OF INTRATHECAL MORPHINE VERSUS INTRATHECAL BUTORPHANOL IN INFRA-UMBILICAL SURGERIES PERFORMED UNDER SUBARACHNOID BLOCK.: 0.15 mg MORPHINE ADMINISTERED WITH 3.5 ML

Sponsors

Office of Principal Midnapore Medical College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: CASES WITH ASA GRADE I AND II CASES WITH HEIGHT BETWEEN 150 TO 180 CMS AND BODY WEIGHT BETWEEN 50 TO 80 KG, BMI BETWEEN 18.5 AND 24.9 CASES UNDERGOING INFRAUMBILICAL SURGERY THAT ARE PERFORMED UNDER SUBARACHNOID BLOCK

Exclusion criteria

Exclusion criteria: CASES WHICH HAVE CONTRAINDICATION FOR SPINAL ANESTHESIA CASES WITH ASA GRADE III AND ABOVE PREGNANT AND LACTATING PATIENTS PATIENTS WITH PSYCHIATRIC ILLNESS CASES WITH HISTORY OF HYPERSENSITIVITY OR ALLERGY TO STUDY DRUGS CASES WITH NEUROPATHY OR NEUROLOGICAL DISORDER PATIENTS WITH ANY ONGOING THERAPIES WITH SUSTAINED RELEASE OPIOIDS ANY PATIENT WITH CARDIORESPIRATORY OR HEPATORENAL DISORDERS IMMUNOCOMPROMISED AND DIABETIC PATIENTS ANY PATIENT REQUIRING ANALGESIC OR ANESTHETIC SUPPLEMENTATION INTRAOPERATIVELY ANY PATIENT CONVERTED TO GENERAL ANESTHESIA ANYTIME AFTER GIVING SPINAL ANESTHESIA , TILL COMPLETION OF SURGERY ANY UNFORESEEN LIFE THREATENING COMPLICATIONS DUE TO SURGERY OCCURING ANYTIME PERIOPERATIVELY

Design outcomes

Primary

MeasureTime frame
TO ASSESS THE DURATION OF ANALGESIA OF MORPHINE AND BUTORPHANOL INTRAOPERATIVELY AND POSTOPERATIVELY UPTO 12 HOURSTimepoint: TO ASSESS THE DURATION OF ANALGESIA OF MORPHINE AND BUTORPHANOL INTRAOPERATIVELY AND POSTOPERATIVELY UPTO 12 HOURS

Secondary

MeasureTime frame
1. HEMODYNAMIC PARAMETERS LIKE HEART RATE, SYSTOLIC BLOOD PRESSURE, DIASTOLIC BLOOD PRESSURE, MEAN BLOOD PRESSURE,Timepoint: PARAMETERS WILL BE NOTED JUST BEFORE ENTERING OT, FOLLOWED BYEVERY 5 MINUTES FOR 30 MINUTES AND 15 MINUTES THEREAFTER TILL COMPLETION OF SURGERY AND FIRST 2 HOURS POSTOPERATIVELY;SEDATION AND OTHER SIDE EFFECTSTimepoint: ASSESSED EVERY 15 MINUTES INTRAOPERATIVELY AND AFTER SURGERY FOR FIRST 2 HOURS AND 30 MINUTES THEREAFTER TILL 12 HOURS POSTOPERATIVELY;SENSORY AND MOTOR BLOCKADETimepoint: BLOCK CHARACTERISTICS WILL BE NOTED TILL SUCCESSFUL INITIATION OF SENSORY AND MOTOR BLOCK AND EVERY 15 MINUTES AFTER SURGERY FOR FIRST 2 HOURS AND 30 MINUTES THEREAFTER TILL 12 HOURS POSTOPERATIVELY;SURGICAL RELAXATIONTimepoint: ASKED FROM MAIN SURGEON AT END OF SURGICAL CLOSURE

Countries

India

Contacts

Public ContactDR DEBALEENA JANA

MIDNAPORE MEDICAL COLLEGE AND HOSPITAL

sumanc24@gmail.com9830234881

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026